Artificial Intelligence (AI)-based healthcare solutions company Tempus AI TEM has continued to capture investors’ attention despite reporting weaker-than-expected fourth-quarter 2024 results on Feb.

We recently published a list of 11 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at ...

The Bureau of Labor Statistics reported Wednesday that February prices for food and services haven’t gone up as much as many ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

It’s been a rocky few days for Tempus AI (NASDAQ:TEM). After hitting a high of $91.45, the stock plummeted to a low of $55.20. All thanks to an earnings miss and news that CEO Jim Rogers sold ...

In this article, we are going to take a look at where Tempus AI, Inc. (NASDAQ:TEM) stands against the other stocks. Wall Street extended a lackluster performance on Tuesday, with two of its major ...

But one ticker that may be less recognizable among the AI crowd is certainly off to a roaring start since the ball fell on New Year's Eve. Skyrocketing 108% since the start of 2025, Tempus AI ...

Tempus AI held its IPO in June 2024 and is applying AI solutions to healthcare. Investors should watch several metrics to assess the company's growth prospects. While Tempus AI could reap big ...